Last edition
News about " kidney transplantation"
Hansa Biopharma's Imlifidase BLA Accepted by US FDA for Priority Review
FDA accepts Hansa Biopharma’s BLA for imlifidase, supported by strong Phase III ConfIdeS data demonstrating significant kidney function improvement in highly sensitized transplant patients.
Kidney Transplantation | 20/02/2026 | By News Bureau | 307
European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases C3G and IC-MPGN
The European Commission has approved Sobi’s Aspaveli for adolescents and adults with rare kidney diseases C3G and IC-MPGN, marking the first approved therapy for these conditions.
Kidney Transplantation | 19/01/2026 | By News Bureau | 196
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy